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Radon, discovered early in the 20th century
as an emanation from radium, is now a well-
characterized human carcinogen. An exten-
sive scientific literature based in experimental
and observational data addresses mechanisms
ofaction at the cellular and molecular levels,
exposures and doses in occupational and gen-
eral environmental settings, and cancer risk,
along with modifiers ofrisk such as smoking.
This literature has been frequently reviewed
and summarized, most recently in the report
ofthe National Research Council's Biological
Effects of Ionizing Radiation (BEIR) VI
Committee (1) released in 1998. The final
report was published in 1999. That report
comprehensively reviewed the literature and
offered new models for estimating the lung
cancer risk associated with radon exposure.
The present review does not replicate that
coverage, and readers seeking a summary of
the scientific evidence should turn to the
BEIRVI report or other recent reviews (2,3).
After a briefsynthesis ofthe current state
of knowledge of radon and cancer, this
review looks to future needs for research on
radon, both for public policy purposes and
for advancing understanding of radon car-
cinogenesis. In fact, our knowledge ofthe
risk posed by radon is relatively advanced
compared to that on many other human car-
cinogens. However, the public policy impli-
cations ofindoor radon are so sweeping that
a high level ofcertainty has been sought by
policymakers about the risks ofthe low levels
of exposures generally found in homes.
Questions have been raised about the scien-
tific basis for the U.S. Environmental
Protection Agency's (U.S. EPA) Radon
Program since its inception in the early
1980s (4). Mounting epidemiologic and lab-
oratory research have steadily reduced critical
uncertainties, and further gains in knowledge
can be projected. Mechanistic research on the
consequences ofcellular irradiation by alpha
partides, directly responsible for the causation
ofcancer by radon, will enhance certainty and
eventuallysupport the development ofbiologi-
cally based models. In the wealth of data
already available and with these exciting
prospects for evolution ofthe evidence, radon
carcinogenesis offers a superb model for link-
ingfrom research to riskassessment to policy.
RadonandLungCancer: AnOverview
The story ofradon as a cause oflung cancer is
a long one with historical accounts document-
ing a fatal lungdisease centuries ago in miners
working in the Erz Mountains of Eastern
Europe (5). Over a century ago, the miners
were found to have thoracic malignancy, later
identified as primary lung cancer. By early in
the 20th century, levels ofradon in the mines
in this region were measured and found to be
quite high; the hypothesis was soon advanced
that radon was the cause ofthe unusuallyhigh
rates oflung cancer. Although not uniformly
accepted initially, as the findings ofepidemio-
logic studies of underground miners were
reported from the 1950s on, there soon was
substantial evidence showing that radon was a
cause ofoccupational lung cancer (1,5). In
fact, the more recent concern about radon in
the air ofhomes was initially driven by the
strong evidence that radon causes lung cancer
in underground miners.
Radon is a noble and inert gas resulting
from the decay of naturally occurring ura-
nium-238. With a half-life of over 3 days,
radon has time to diffuse through rock and
soil after it forms and before undergoing fur-
ther decay into its particulate progeny. In
mines, it enters the air from the ore or is
brought into the mine dissolved in water. In
homes, the principal source is soil gas, which
penetrates through cracks or sumps in base-
ments or around a concrete slab. Because ura-
nium-238 is universally present in the earth,
radon is a ubiquitous indoor air pollutant,
and it is also present in outdoor air, albeit at
far lower concentrations. Infrequently, build-
ing materials or water also may contribute
significantly to indoor concentrations.
Radon is an alpha emitter that decays
with a half-life ofabout 3.5 days to a short-
lived series ofprogeny (Figure 1) (1). Unlike
radon, the progeny are solid and form into
small molecular clusters or attach to aerosols
in the air after their formation. The inhaled
particulate progeny may be deposited in the
lung on the respiratory epithelium; radon by
contrast is largely exhaled, although some
radon is absorbed through the lung. Radon
itselfis not responsible for the critical dose of
radioactivity delivered to the lung that causes
cancer. While radon was initially thought to
be the direct cause ofthe lung cancer in the
miners, Bale (6) and Harley (7) recognized in
the early 1950s that alpha particle emissions
from radon progeny and not from radon itself
were responsible for the critical dose ofradia-
tion delivered to the lung. Alpha decays of
two radioisotopes in the decay chain,
polonium-218 and polonium-214 (Figure 1),
deliver the energy to target cells in the respira-
tory epithelium that is considered to cause
radon-associated lung cancer (8). Alpha parti-
cles, equivalent to a helium nucleus, are
charged and have a high mass. Although their
range of penetration into tissues is limited,
they are highly effective at damaging the
genetic material ofcells. As reviewed in the
report of the BEIR VI Committee (1), pas-
sage ofeven a single alpha particle through a
cell can cause permanent genetic change in
the cell.
Evidence on radon and lung cancer risk is
now available from approximately 20 different
epidemiologic studies ofunderground miners,
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including 11 studies that provide quantitative
information on the exposure-response rela-
tionship between exposure to radon progeny
and lung cancer risk (1,5). Occupational risks
of radon-caused lung cancer have been
described in many reports on the findings of
the individual studies and in several pooled
analyses ofthe data from the 11 studies with
quantitative information (1,10). There is a
surprising degree ofconsistency among the
risks estimated in these studies; the risk coeffi-
cients span approximately a single order of
magnitude, in spite ofsubstantial method-
ologic differences among the studies (1). In
general, the temporal patterns ofexcess risk
following exposure are also similar among the
studies; that is, risks change in a similar fash-
ion with time since exposure and with age of
the individual.
Although radon progeny are now a well-
recognized occupational carcinogen, radon
became a topic ofcontroversy again in the
1970s and 1980s because itwas found to be a
ubiquitous indoor air pollutant in homes,
and recommended control strategies in the
United States and other countries included
testing of most homes and mitigation of
those levels exceeding suggested guidelines
(4). Radon was found to be present in indoor
air as early as the 1950s, but potential health
implications received little notice until several
decades later. The problem first received the
greatest attention in Scandinavia, but homes
with radon levels ofconcern have now been
identified in other countries ofEurope and in
North America. Housing surveys show that
radon is ubiquitous and that concentrations
tend to follow a log-normal distribution
(Figure 2). Policies are now in place in many
countries to manage the lung cancer risk asso-
ciated with indoor radon. These policies
involve identification and mitigation ofradon
levels in homes with concentrations above
guideline values and use ofconstruction tech-
niques that reduce radon concentrations.
Since these policies potentially extend to
almost all residential housing, their scientific
base has been challenged, as has their cost
effectiveness.
Initially, risks ofindoor radon were esti-
mated primarily by extrapolating the risks
observed in the studies ofunderground min-
ers to the exposures sustained by the general
population indoors. In this risk assessment
approach, key uncertainties reflected the use
of risk estimates from relatively short-term
exposures at concentrations substantially
above those typically found in homes, the
extension of estimates from men, largely
smokers, to the entire population, and differ-
ing dosimetry ofradon progeny for the cir-
cumstances of exposures in mines and in
homes. Linear nonthreshold models were
used for the extrapolation from higher to
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lower exposures, which invited the criticism
that risks were overestimated. Lung models
were used to address the potential uncertainty
from differing dosimetries in homes and
mines, with the finding that exposure-dose
relations were quite comparable for the min-
ers and for the general population (8).
To develop risk estimates directly from
the general population, case-control studies
were initiated beginning in the 1980s (1,5).
The basic design of these studies involved
comparison ofestimated radon exposures for
lung cancer cases with those ofappropriate
controls. Radon exposures were estimated by
making measurements ofradon concentra-
tions, generally over several months to ayear,
in the current and former residences ofcases
and controls. The case-control studies were
soon recognized as being subject to substan-
tial bias toward a null finding because of
unavoidable errors in the exposure estimates;
such errors arose from missing data and
errors in the radon measurements (11).
Consequently, plans were made for pooling
the data from the individual studies (12).
Initial pooling ofdata from North America
and Europe is now in progress and a pooling
ofall ofthe studies should be completed by
approximately 2002. In the meantime, the
findings ofthe completed studies have been
combined using meta-analysis (1,13). The
risk estimate derived from the eight com-
pleted studies is indicative ofan effect fully
consistent with the risk extrapolations from
the miner studies (Figure 3).
Although risk management for indoor
radon remains controversial, the evidence on
radon and lung cancer is now very extensive.
Initially, epidemiologic and other research
was driven by the need to characterize the
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Figure 1. The radon-decay chain. An arrow pointing downward indicates decay by alpha-particle emission; an arrow
pointing to the right indicates decay by beta-particle emission The historical symbols for the nuclides are in paren-
theses below the modern symbols. Most decay takes place along the unbranched chain marked with thick arrows.
The negligible percentage of decay along the thin arrows is shown atcritical points The end of the chain lead 206,
is stable not radioactive. Half-lives of each isotope are shown as seconds (s), minutes (m), days (d), or years (y).
Modified from the National Research Council (1).
Figure 2. Distribution of radon concentrations in U.S.
homes. Modified from the U.S. EPA(4).
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risks faced byunderground miners in order to
set exposure limits thatwould have acceptable
risks. This work emphasized epidemiologic
approaches, but animal studies were also con-
ducted to confirm the hazard and to address
the modifying effects ofsuch factors as the
presence ofore dust and diesel exhaust, ciga-
rette smoking, and dose rate (14). More
recently, research has reflected the need to
understand better the risks posed to the gen-
eral population by indoor radon. Epidemio-
logic studies have been conducted to assess
directly the general population's risk oflung
cancer from indoor radon; laboratory studies
using molecular and cellular approaches have
been conducted to better understand the
mechanism ofradon carcinogenesis and to
address key uncertainties in assessment ofthe
risks ofindoor radon.
Over the last several decades, risk models
have been developed for risk assessment and
risk management ofindoor radon. However,
lung cancer risk in underground miners has
long been ofinterest; in fact, the first attempt
to quantify risk was made by Evans and
Goodman (15) in their 1940 report based
on the radon measurements made in the
Schneeburg and Joachimsthal mines. Key
reports have come from the International
Commission for Radiological Protection
(ICRP), the National Council for Radiation
Protection and Measurements, and the BEIR
Committees ofthe U.S. National Research
Council. Samet (16) has reviewed the evolu-
tion of risk assessment for radon and lung
cancer. To illustrate the contemporary
approach to radon risk assessment, the mod-
els developed by the BEIRVI Committee are
described below.
Conceptually, the BEIR VI Committee
extended the approach used a decade earlier
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Figure 3. Relative risks from 8 lung cancer case-control
studies of indoor radon. - - - -, extrapolation of risk from
miners (10). . relative riskof 1.
by the BEIR IV Committee, i.e., developing
an empiric, time-dependent model for lung
cancer risk from the miner data and then
extending that model to the general popula-
tion with consideration ofthe possibility of
differing exposure-dose relations in homes
and in mines and ofsmoking, the most criti-
cal potential modifying factor. The BEIR VI
Committee used the pooled data set from the
11 miner cohorts and the 1994 analysis of
Lubin et al. (10) as a starting point for devel-
oping its risk models (1). The pooled data set
included more than 2,700 lung cancer deaths
among 68,000 miners followed for nearly 1.2
million person-years ofobservation. This data
set was substantially larger than that consid-
ered by the BEIRIVCommittee.
Most analyses were based on a linear
excess relative risk (ERR) model:
RR = 1 + iworERR = iw,
where RR is relative risk, P is a parameter
measuring the unit increase in ERR per unit
increase in w, and w is cumulative exposure
to radon progeny in WLM (working level
months is the unit of exposure used for
undergound miners; lifetime exposure
indoors is approximately 14 WLM). As in the
BEIR IVanalysis, ERRwas linearly related to
cumulative exposure to radon progeny. The
ERRIWLM varied significantly with other
factors; it decreased with attained age, time
since exposure, and time after cessation of
exposure but was not affected significantly by
age at first exposure. Over a wide range of
total cumulative exposures to radon progeny,
lung cancer risk was increased as exposure
rate declined, confirming the pattern reported
from the Colorado Plateau study (17), and
supporting the prior hypothesis ofan inverse
dose-rate effect (18). The inverse dose-rate
effect implies that the lower rates ofexposure,
typical ofhomes, could increase risk more
than projected from estimates made at the
generally higher exposures experienced by the
miners. The extent ofthe information avail-
able at lower levels of exposure permitted
analyses ofrisks in a range ofexposures of
greatest relevance to exposures associated with
indoor radon. With the data restricted to
cumulative exposures below 200 WLM, there
was no evidence for departure from a linear
model and the exposures were in a range at
which an inverse dose-rate effect was not
expected on abiophysical basis (1).
The BEIRVI (1) report provides risk esti-
mates for various scenarios of exposure to
radon and also makes projections ofthe bur-
den of lung cancer in the United States
attributable to radon progeny (Table 1).
These estimates are provided in Table 1,
which includes the figures for the total popu-
lation and for smokers and never-smokers
separately. The estimates for smokers and
never-smokers are based on the assumption of
a submultiplicative combined effect ofsmok-
ing and radon progeny. The submultiplica-
tive relationship was estimated from the
studies with data available on both smoking
and exposure to radon progeny; it implies
synergism between the two factors, but the
degree ofsynergism is less than fully multi-
plicative. Estimates based on the BEIR IV
model are included in the tables along with
estimates based on fitting a constant relative
risk model to the data at exposures less than
50 WLM, the lowest level ofexposure with
sufficient data available for analysis. The
BEIR VI report also includes a quantitative
uncertaintyanalysis.
These estimates confirm that radon prog-
eny should be considered a significant cause
of lung cancer in the United States. The
attributable risks are higher on a percentage
basis for never-smokers than smokers, reflect-
ing the submultiplicative interaction between
smoking and radon progeny. The numbers of
Table 1. Estimated attributable riska for lung cancer death from domestic exposure to radon using 1985-1989 U.S.
population mortality rates based on selected risk models.
Model Population Ever-smokersb Never-smokersb
Males
Committee's preferred models
Exposure-age-concentration 0.141 0.125 0.258
Exposure-age-duration 0.099 0.087 0.189
Other models
CRRc(< 50WLM) 0.109 0.096 0.209
BEIR IV 0.082 0.071 0.158
Females
Committee's preferred models
Exposure-age-concentration 0.153 0.137 0.269
Exposure-age-duration 0.108 0.096 0.197
Other models
CRR ( 50WLM) 0.114 0.101 0.209
BEIR IV 0.087 0.077 0.163
CRR, constant relative risk.
'The risk of lung cancer death attributed to radon in populations exposed to radon divided by the total risk of lung cancer death in a
population. bBased on a submultiplicative relationship between tobacco and radon. Data from the National Research Council I1).
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attributable cancer deaths are far higher in
smokers than in never-smokers. Ofthe lung
cancer deaths attributed to radon exposure,
only a minority can be prevented by current
risk management strategies, as the total num-
ber ofdeaths attributed can, in theory, be
prevented only by lowering levels of radon
progeny indoors to outdoor values. For the
United States, about one-third ofthe radon-
related lung cancer deaths are attributed to
concentrations above the current guideline of
the U.S. EPA.
OpenQuiestions ConcerningRadon
andLungCancer
Asevident from even this briefreview, we have
a broad and rich evidence base on radon and
lung cancer, one that has proved sufficient for
developing policies for radon control. Yet, pol-
icy makers are seeking greater certainty and
there are still open scientific questions to be
investigated. Additionally, there is the poten-
tial for combining laboratory-based under-
standing ofmechanisms with observational
data to develop a true, biologically based risk
model. These questions and potential research
approaches arediscussed in the nextsection.
WhatIstheMechanismofRadon
Carcinogenesis?
We are poised to make substantial advances
in our understanding ofmechanisms ofcar-
cinogenesis by alpha particles, which are
directly responsible for the induction oflung
cancer by radon. The BEIR VI Report (1)
provides an overview ofrecent advances in
the molecular and cellular basis ofcancer cau-
sation by alpha particles and directly links
these advances to their risk assessment impli-
cations. This synthesis makes clear the link-
ages between molecular and cellular research
and key uncertainties in risk assessment: the
assumption ofa linear nonthreshold model at
the lowest levels ofexposure and the magni-
tude and existence ofdose-rate effects at low
levels ofexposure. Experimental systems have
also been designed to explore combined
effects ofradon exposure and tobacco smok-
ing, but these models cannot replicate the
complex and sustained exposure to carcino-
gens and irritants typical ofhuman smoking.
New experimental methods involving sin-
gle-cell irradiation with alpha particles appear
particularly promising as tools for exploring
the effects ofalpha particles on the cell (159.
Using this experimental model, it is possible
to characterize effects on cells using single
particles ofvarying energy and to explore the
consequences ofmultiple versus single hits to
the cell nucleus. Permanent cellular changes
following single-cell irradiation were consid-
ered by the BEIR VI Committee as evidence
of the appropriateness ofassuming a linear
nonthreshold relationship between exposure
and lung cancer risk. Further advances in our
understanding ofthe basis ofradon carcino-
genesis are likely to bring the greatest gain in
certainty for risk models for the future, as we
have already completed a relatively complete
synthesis ofthe epidemiologic evidence.
What IstheRiskofTypicalIndoor
Radon Concentrations?
In the United States and other countries for
which survey data are available, the concen-
trations ofradon in homes follow an approxi-
mately log normal distribution (Figure 2).
For risk management purposes, we conse-
quently need estimates ofthe risks ofthe high
end ofthe distribution (which overlaps sub-
stantially with the concentrations at which
miners were exposed) and ofthe risks at typi-
cal indoor levels (which are much lower than
those to which the miners were exposed in
the epidemiologic studies). The population's
burden ofattributable risk is driven by the
broad end ofthe distribution, which is cen-
tered around the geometric mean, whereas
clearly unacceptable individual risks come
from the upperendofthe distribution.
This risk estimation problem has been
approached by a) extending the exposure-
response relationship for radon progeny expo-
sure andlungcancerobserved in the miners to
the general population; and b) attempting to
direcdyestimate risk to thegeneral population
by conducting case-control studies. The for-
mer approach is subject to the principal
uncertainties arising from the generalization of
risks observed in male miners, differing
dosimetry ofradon progeny in homes and
mines, and extrapolation from higher to lower
exposures. The latter approach, using risk esti-
mates from case-control studies, has proved
more difficult than anticipated when the
studies were initiated. Daunting problems in
estimating exposures to radon indoors
markedly blunt the sensitivity of the case-
control studies and limit the precision ofrisk
estimates from their data (9,11,20). These
problems include finding and gaining access
to residences and assuming that contempora-
neously measured concentrations reflect past
values. The uncertainties in both approaches
to estimating the risks oflower levels of
indoor radon continue as a source ofcontro-
versyand ofweakness in the scientific founda-
tion for managing the riskofindoorradon.
The epidemiologic evidence from the
miners will become stronger as more follow-
up time is accrued, particularly from the
more recent cohorts with the lowest exposure.
Additional cohort studies, particularly in
Czechoslovakia (21) and the former East
Germany (22), may also be informative. As
the limitations ofthe individual case-control
studies were recognized (11), plans were
made to pool the results ofthe studies for risk
estimation. Although the findings ofthe indi-
vidual studies reportedto date seeminglyhave
been inconsistent, when construed (improp-
erly) as positive or negative, meta-analysis
shows the findings to be reasonablyconsistent
andwith evidence ofa positive dose-response
relationship, similar to those predicted from
the miner data (1,13). Plans have now been
completed to pool the data from the
case-control studies at the individual partici-
pant level. This pooling will bring this line of
investigation to a close, giving the greatest
powerandprecision presentlyachievable.
The observational evidence may be
strengthened by improved methods for expo-
sure estimation and by using emerging meth-
ods for estimating exposure. The exposure
estimates in the epidemiologicstudies ofmin-
ers are based on limited and incomplete data
and pragmatic approaches [reviewed by the
National Research Council (1)]. Undoubt-
edly there is substantial random error in the
exposure estimates and possibly systematic
error as well (e.g., systematic over- or under-
estimation ofsome exposures). This problem
has long been recognized and biodosimetric
methods have been developed as one poten-
tial solution, induding measurement oflead-
210 (the long-lived radioisotope that ends the
radon progeny decay series) in red blood cells
and in bone, by use ofautopsy materials, or
by skull counting. The sensitivity ofskull
counting has been enhanced (23), although
notyet to levels sufficient for the lowerend of
miner exposure. Nonetheless, skull counting
offers a potential approach for assessing the
degree oferror affecting exposure estimates in
the epidemiologic studies and making adjust-
ments using statistical methods considered
below. Using the skull-counting method is
currently beingexplored in studies ofChinese
tin miners and NewMexico uranium miners.
The problems ofexposure estimation in
the case-control studies may be partially sur-
mounted using glass (e.g., covering pictures)
as an exposure indicator. Long-lived progeny
embedded in the surface ofglass over time
emit alpha particles, which can be counted as
an index of the concentration of radon to
which the glass has been exposed (24,25).
This approach has now been incorporated
into several of the case-control studies
(26,24-). In a case-control study in Missouri,
Alavanja et al. (27) found a significant, posi-
tive relationship between radon exposure and
lung cancer risk, using glass-based exposure
estimates, but not with estimates based on
radon concentration in air. This finding sug-
gests that exposure misclassification was
reduced by using the glass-based estimates.
This technique might be retrospectively used
in other case-control studies to estimate the
degree of exposure misclassification to
accomplish adjustment.
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With new statistical methods for consid-
ering measurement error, adjustments can be
made to risk estimates (28). In the BEIR VI
report, Thomas and colleagues (29) describe
one approach that is undergoing further elab-
oration and Spiegleman and Logan (30) also
apply measurement error correction methods
to uranium miner data. These methods will
inflate risk estimates in comparison with
those derived from the uncorrected estimates
used in the analyses to date.
Advances in the understanding of the
molecular and cellular basis ofcarcinogenesis
by alpha particles offer the greatest promise
for reducing uncertainty in radon risk esti-
mates. Together, microdosimetric considera-
tions and experimental findings support the
theory that a single alpha particle can perma-
nentlychange cellular DNA (1). The assump-
tion ofa nonthreshold and linear model at
low doses already appears quite tenable (1).
The application of methods for single-cell
irradiation will continue to inform risk assess-
ment. For example, Miller et al. (31) exam-
ined the frequency of cell transformation
following exposure ofcell nuclei to exactly
one alpha particle, compared with an average
ofone particle under a Poisson distribution.
The rate oftransformation was substantially
lower with exactly one hit, leading the
investigators to suggest that risk estimates
made at higher exposures could overestimate
risks at low exposures, where only one hit can
be expected. This research is illustrative ofthe
type ofexperiment thatdirectlyaddresses akey
uncertaintyin riskestimates forradon (19,32).
We should be moving toward develop-
ment ofbiologically based risk models, based
on an underlying theoryofradon carcinogen-
esis. Findings from the alpha particle irradia-
tion studies will prove useful in developing
such models. Moolgavkar et al. (33) and
Luebeck et al. (34) have already applied the
two-stage model ofcarcinogenesis to data
from underground miners, illustrating the
potential for biologically based modeling of
epidemiologic data. Parallel analyses ofani-
mal data also have been carried out (35).
Advances in the underlying biologic basis for
such modelswill strengthen this approach.
IsRadonaGlobalPublicHealth
Problem?
Throughout the world, particularly in coun-
tries in temperate and colder climates, indoor
radon is probably a dominant contributor to
radiation exposure (36). A review ofsome
recent literature shows that there are numer-
ous surveys documenting indoor concentra-
tions ofradon in developing and developed
countries around the world (Table 2).
Although there is likely to be a range of
potential modifying factors among these
countries, particularly cigarette smoking, the
risk models developed by the BEIR VI
Committee and other groups remain relevant
for guiding policy. Extension ofthese models
to other countries would identify some as
having an unacceptable burden oflungcancer
and theworld's total burden ofcancers attrib-
utable to radon undoubtedly would be large
ifestimated. Policy development and imple-
mentation is another matter and the relevance
of policies adopted in North America or
Europe is uncertain. Guidance should be
developed by those organizations concerned
with radiation protection internationally-
the ICRP and the United Nations.
HowCanWeProtectandCompensate
UraniumMiners?
The number ofmen and women who mined
uranium underground in the countries ofthe
West and ofthe former Soviet Union will
Table 2. Indoor concentrations ofradon: results ofsurveys.
Geometric mean Geometric Max range
Country Year of survey Dwellings surveyed(no.) in pCi/L(Bq m-3) SD (Bq m-3)
Italy(47 1989-1994 - survey began 4,866 57 Bq m-3 2.0
in March
Russia (48) 1995-1996 Bq m-3
April-July 190 195 115
October-December 380 653 206
January-March 253 640 190
Russia (49) 1993-1994 - inthe summer; 105 32 Bq m-3 180 Bq mi3
morning
Japan 1985 - InJanuarytwodetectors 100 56.8 Bq m-3 2.7
Hiroshima and were placed in 189 houses; 99 28.5 Bq m-3 2.2
Nagasaki (50) one detector in 11 houses.
Detectors were left until
October 1985
Israel (51) 1995- December Jerusalem public school (six >10,000 Bq m3
grades, 600students)
Jordan(52) 1995 -September-December 9majorcities(35 zoneseach) Radon and thoron concentration levels
Bag dosimeters - 32-107 Bq mi3
Cup dosimeters - 27-88 Bq m-3
Hong Kong (53) 1995 - late November- 10 underground shopping 29.2 ± 7.8 Bq m3
March 1996 centers surveyed; 58dwelling
1996 -August-early December sites
Southwest England 1989-1992 1.5 million (28,900 tumors <40 Bq m3
(54) werecounted) >230Bq m3
Poland (55) 1991 - three months 310 detectors randomly 2.2 pCi/L >4pCi/L
1,099(lung cancer)
Kenya (56) 200 watersamples 222Rnactivity concentration ranges
from 0.8 ± 0.5to 31.7 ± 33.5 Bq L-1
Thailand (57) 1995 - October 387 samples 179.74 and
263.38 Bq m-3
Idaho(58) 1994 1,300groundwatersamples 17.7 Bq L-'
SD, standard deviation.
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never be known, but an estimate of about
1 million may be reasonable (37). In the
United States, thousands worked in the
Colorado Plateau region (38) and the peak
number ofundergroundworkers in the Grants
Uranium beltwas as high as 4,000-5,000. We
knownowthat several hundred thousand min-
ers worked in the former East Germany (39)
and the number who worked in
Czechoslovakia may have been as large. In
China, the epidemiologic cohort ofYunan tin
miners numbers around 17,000 and this is a
selected group from the total population.
Relative risks and attributable risks for lung
cancer in the miner cohorts are high (1), pro-
viding strong evidence ofan epidemic ofoccu-
pational lung cancer in the miners. Most
certainly, there will also be high rates ofsilico-
sis and silicotuberculosis among miners, and
there is still a question aboutwhether uranium
miners alsodevelop pulmonary fibrosis (1,40).
Uranium exploration and mining began
after World War II in the climate ofurgency
spawned by the Cold War and the nuclear
arms competition. The historical record
clearly shows that the health and safety of
underground uranium miners was neglected
in the United States (38,41,42) and almost
certainly in other countries as well.
Unfortunately, many former miners who
developed lung cancer have not received any
compensation in spite ofthe circumstances
under which they worked. In the United
States, miners or their families sought com-
pensation through the workmens' compensa-
tion system with varying success. The
Radiation Exposure Compensation Act,
passed in 1990 (41), offers an apology to the
miners and provides financial compensation
to miners or their families who meet criteria
for exposure and diagnosis. While the act is
well-intentioned, there are evident problems
in its provisions that need to be addressed
through scientifically based revisions (43).
The miner data have been analyzed to
develop a risk model for this purpose, illus-
trating one potential approach to evidence-
based compensation (44). The relationship
between compensation schemes in other
countries and the epidemiologic evidence
should also be evaluated.
Uranium mining continues throughout
the world, although much of the ore pro-
duction is from surface mines, which fortu-
nately results in relatively low exposures.
Underground mining persists, however
(36,37). The mounting epidemiologic and
experimental evidence indicates that there is
no safe level of radon exposure and a life-
time ofworking at current exposure limits is
projected to carry an unacceptable risk (1).
Epidemiologic surveillance of currently
exposed underground miners is warranted,
perhaps employing new approaches for
monitoring with biomarkers (45,46).
Current and former miners, as a population
at high risk for lung cancer, are also poten-
tially useful sources of information for
studies of chemoprevention and molecular
markers ofthe early stages ofcarcinogenesis.
Summary and Conclusions
The story ofradon and lung cancer is remark-
able for its length and its many twistings and
turnings. We have long known that under-
ground miners are at risk for lung cancer and
have had evidence establishing radon as a
cause oflung cancer since mid-century. A
wealth ofepidemiologic data from the under-
ground miners provides a quantitative picture
ofthe lung cancer risk caused by radon and
these observational data are well buttressed in
a substantial body ofexperimental evidence.
This body ofexperimental and observational
evidence has proved informative for estimat-
ing the risks ofindoor radon, a more recent
problem, and observational studies that
directly estimate the risks of indoor radon
indicate that the indirect approach using the
miner data appears on target. In fact, the
totality of the evidence on radon and lung
cancer is noteworthy for its scope. There are
few carcinogens for which such extensive epi-
demiologic data are available, particularly
data extending into the range ofexposures
experienced bythe general population.
Policies for control of radon remain
under attack, however, as does their scientific
basis. Further research drawing on molecular
and cellular approaches and further follow-
up of underground miner cohorts should
help alleviate much remaining criticism.
Within a few decades, we should be able to
construct mechanistically based risk models
that combine epidemiologic and experimen-
tal data to yield radon exposure estimates
with enhanced certainty.
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